Jersey’s medical cannabis industry turned a profit for the first time in 2025, posting revenues of £12m, almost £50m in cumulative investment, and exports of nearly seven tonnes.
GW Pharmaceuticals has released further details of its cannabis development pipeline.
CHANGES to immigration policy post-Brexit has resulted in a shortage of seasonal labour at UK-based medicinal cannabis cultivation sites, claims the company that owns Britain’s largest such operation.
LEADING UK cannabis company GW Pharmaceuticals has received the Queen’s Award for Enterprise 2021 in recognition of its ground-breaking work in creating the world’s first regulatory approved, prescription cannabis-based medicines.
THE last few weeks have witnessed a wild ride for global cannabis stocks reminiscent of some of the earlier bubbles experienced by the sector.
Good morning. Today is another post-Tom Brady Super Bowl Monday… Last week was a busy week one in cannabis last week – with a major acquisition and more (and more) US states looking toward legalization.
IRISH firm Jazz Pharmaceuticals has agreed to purchase UK medical cannabis trailblazer GW Pharmaceuticals for $7.2bn.
Well, this is the last Monday newsletter of 2020. For that, we are thankful.
THE emerging cannabis industry is moving up the agenda for the pharmaceutical industry with two significant deals announced in the last few months.
